These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30249463)

  • 1. Background parenchymal enhancement in breast magnetic resonance imaging: A review of current evidences and future trends.
    Rella R; Bufi E; Belli P; Contegiacomo A; Giuliani M; Rosignuolo M; Rinaldi P; Manfredi R
    Diagn Interv Imaging; 2018 Dec; 99(12):815-826. PubMed ID: 30249463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of background parenchymal enhancement on breast MRI: a systematic review.
    Bignotti B; Signori A; Valdora F; Rossi F; Calabrese M; Durando M; Mariscotto G; Tagliafico A
    Br J Radiol; 2017 Feb; 90(1070):20160542. PubMed ID: 27925480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Diagn Interv Imaging; 2016 Mar; 97(3):315-20. PubMed ID: 26970658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.
    Zeng L; Lo G; Moshonov H; Liang J; Hodgson D; Crystal P
    Acad Radiol; 2016 Feb; 23(2):168-75. PubMed ID: 26546383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk.
    Grimm LJ; Saha A; Ghate SV; Kim C; Soo MS; Yoon SC; Mazurowski MA
    Acad Radiol; 2019 Jan; 26(1):69-75. PubMed ID: 29602724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
    Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
    Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
    Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
    J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker.
    Rella R; Contegiacomo A; Bufi E; Mercogliano S; Belli P; Manfredi R
    Br J Radiol; 2021 Mar; 94(1119):20200630. PubMed ID: 33035073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.
    Preibsch H; Richter V; Bahrs SD; Hattermann V; Wietek BM; Bier G; Kloth C; Blumenstock G; Hahn M; Staebler A; Nikolaou K; Wiesinger B
    Eur J Radiol; 2017 May; 90():181-187. PubMed ID: 28583631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
    Leithner D; Baltzer PA; Magometschnigg HF; Wengert GJ; Karanikas G; Helbich TH; Weber M; Wadsak W; Pinker K
    J Nucl Med; 2016 Oct; 57(10):1518-1522. PubMed ID: 27230924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.
    Sung JS; Corben AD; Brooks JD; Edelweiss M; Keating DM; Lin C; Morris EA; Patel P; Robson M; Woods M; Bernstein JL; Pike MC
    Breast Cancer Res Treat; 2018 Nov; 172(2):487-496. PubMed ID: 30140962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of association between degree of background parenchymal enhancement on MRI and breast cancer subtype.
    Ha R; Mango V; Al-Khalili R; Mema E; Friedlander L; Desperito E; Wynn RT
    Clin Imaging; 2018; 51():307-310. PubMed ID: 29945057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI Texture Analysis of Background Parenchymal Enhancement of the Breast.
    Amano Y; Woo J; Amano M; Yanagisawa F; Yamamoto H; Tani M
    Biomed Res Int; 2017; 2017():4845909. PubMed ID: 28812015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
    AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
    Haga M; Hirai T; Nakai T; Kobayashi T; Nakamura T; Marugami A; Ito T; Takewa M; Marugami N; Kichikawa K
    J Med Ultrason (2001); 2020 Oct; 47(4):591-601. PubMed ID: 32989596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
    Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
    Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning-based prediction of future breast cancer using algorithmically measured background parenchymal enhancement on high-risk screening MRI.
    Saha A; Grimm LJ; Ghate SV; Kim CE; Soo MS; Yoon SC; Mazurowski MA
    J Magn Reson Imaging; 2019 Aug; 50(2):456-464. PubMed ID: 30648316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis.
    Ben-David MA; Corn BW; Evron E; Goldberg H; Pfeffer RM; Abdah-Bortnyak R; Matceyevsky D; Weinstein Y; Golan O; Sklair-Levy M
    Breast; 2020 Feb; 49():70-73. PubMed ID: 31734591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.
    Giess CS; Yeh ED; Raza S; Birdwell RL
    Radiographics; 2014; 34(1):234-47. PubMed ID: 24428293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
    Vreemann S; Dalmis MU; Bult P; Karssemeijer N; Broeders MJM; Gubern-Mérida A; Mann RM
    Eur Radiol; 2019 Sep; 29(9):4678-4690. PubMed ID: 30796568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.